Sarissa Capital
amarin has always run negative cash flows from operations since its drug was approved in | Sarissa Capital
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
15 of 109
Related slides by other companies
3M
Results
April 2023
cash flow and balance sheet | 3M
DTE Electric
Investor Presentation
September 2022
cash flow and capital expenditures guidance | DTE Electric
3M
Results
May 2023
cash flow and balance sheet | 3M
NVIDIA
Investor Day
April 2021
cash flow and capital allocation arm | NVIDIA
Other recent decks by Sarissa Capital
See all presentations (7 decks)
Activist
June 2023
Activist
June 2023
Activist
June 2023
Activist
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io